Skip Navigation

Cardiovascular Research 2003 59(3):534-535; doi:10.1016/S0008-6363(03)00557-1
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Neumann, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neumann, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

A renaissance of positive inotropic interventions to treat heart failure?

Joachim Neumann*

Institut für Pharmakologie und Toxikologie, Universitätsklinikum Münster, Domagkstr. 12, D-48129 Münster, Germany

neumannjoachim@hotmail.com

* Tel.: +49-251-835-502; fax: +49-251-835-5501.

The first 10% of the full text of this article appears below.

See article by Kögler et al. [1] (pages 582–592) in this issue.

Heart failure has a high and increasing prevalence due to the aging population and the better survival rates in other heart diseases (e.g. acute myocardial infarction) in the Western world. Myocardial oxidative stress due to increased production of reactive oxygen free radicals may play an important role in the development and progression of heart failure.

In this issue of Cardiovascular Research, Kögler et al. [1] . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?